rituximab,venetoclax,azacitidine,tamibarotene,lenalidomide
abbvie,roche
['select,mds1', 'valeria', 'leukemia', 'mds']
congress | #ash22 valeria santini, compares ipss, ipss-r, and ipss-m scoring systems in the phase ii stimulus-mds1 and phase iii stimulus-mds2 patient populations. results indicate that molecular and cytogenetic assessment will improve evaluation in clinical trials. 
Lifting levels of knowledge in myelodysplastic syndromes (#MDS). A global online platform providing latest treatment options and medical information. #mdssm